CD8A and neoplasm: Cheng et al. reported that intradermal immunization with a DNA vaccine encoding a fusion protein between CRT, or CRT fragments, and E7 tumor antigen was more efficient for eliciting E7-specific CD8+ T cells and protecting against E7-expressing tumors in C57BL/6 mice [41].